Biotech/Healthcare are certainly seeing inflows of money from institutions. The RS on this name along with the clear volume accumulation is really nice. Potential consolidation into ATH Breakout.
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。